Natera, INC Form 4 insider transactions

Director Marcus Gail Boxer acquired 488 Restricted Stock Units (RSUs) of Natera, Inc. on April 26, 2024, which vest over one year.

Director Rowan E. Chapman acquired 488 shares of Natera, Inc. through the issuance of Restricted Stock Units (RSUs) on April 26, 2024.

Director Rosenman Herm of Natera, Inc. reports acquiring common stock and restricted stock units (RSUs) on April 26, 2024, according to a Form 4 filing with the SEC.

Director Roelof Botha reports acquisition of Natera, Inc. stock through restricted stock units (RSUs).

Jonathan Sheena, co-founder of Natera, Inc., sold 1,000 shares of common stock on April 25, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Natera's CFO, Michael Brophy, executed multiple sales of common stock between April 24 and April 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., reports transactions involving common stock and restricted stock units.

Daniel Rabinowitz, SEC and Chief Legal Officer of Natera, Inc., reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 531 shares of common stock to cover tax obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 522 shares of common stock on April 23, 2024, to cover tax obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, reports the acquisition and disposal of common stock and restricted stock units to cover tax obligations.

Michael Brophy, CFO of Natera, Inc., reports the vesting and sale of restricted stock units to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold a total of 80,000 shares of common stock on April 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Natera's CEO, Steven Chapman, sold shares of the company's common stock on April 15, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on April 3, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Natera's CFO, Michael Brophy, sold 1,378 shares of common stock on April 2, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., reports the acquisition and disposition of common stock and restricted stock units.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., reports the vesting of Restricted Stock Units and subsequent sale of shares to cover tax obligations.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold 707 shares of common stock to cover tax obligations related to vesting RSUs.

John Fesko, President and Chief Business Officer of Natera, Inc., sold 464 shares of common stock on March 28, 2024, to satisfy tax withholding obligations related to vesting RSUs.

Natera's CEO, Steven Chapman, executed multiple sales of common stock in March 2024 under a pre-arranged Rule 10b5-1 trading plan and to cover tax obligations related to vesting RSUs.

Michael Brophy, CFO of Natera, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Roelof Botha exercised stock options of Natera, Inc. on March 15, 2024, resulting in the acquisition and disposal of common stock.

Natera's CEO, Steven Leonard Chapman, reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Jonathan Sheena, co-founder of Natera, Inc., reports gifting shares of common stock and shares held in trust for minor children.

Jonathan Sheena, co-founder of Natera, Inc., sold shares of common stock on March 5th and 6th, 2024, to cover tax obligations and under a pre-arranged Rule 10b5-1 trading plan.

Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER of Natera, Inc., reports selling 2,160 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.

Natera CEO Steven Chapman sold 9,326 shares of common stock on March 5, 2024, to satisfy tax withholding obligations related to vesting Restricted Stock Units.

Natera's CFO, Michael Brophy, sold 2,826 shares of common stock on March 5, 2024, to satisfy tax obligations related to vesting Restricted Stock Units.

Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., reports the acquisition and disposal of company stock related to RSU vesting and tax obligations.